Monte Rosa Therapeutics Inc (GLUE) — Cash Flow Reinvestment Rate
Monte Rosa Therapeutics Inc (GLUE) has a Cash Flow Reinvestment Rate of 0.39x as of September 2025, reinvesting $38.79 Million (capex $651.00K plus investments $38.14 Million) from operating cash flow of $100.43 Million. Explore Monte Rosa Therapeutics Inc capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Monte Rosa Therapeutics Inc Cash Flow Reinvestment Rate (2024–2024)
Historical reinvestment intensity for Monte Rosa Therapeutics Inc across 1 annual periods. Also explore Monte Rosa Therapeutics Inc (GLUE) total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Monte Rosa Therapeutics Inc (2024–2024)
Year-by-year capital reinvestment analysis for Monte Rosa Therapeutics Inc. For live market cap and broader valuation context, see Monte Rosa Therapeutics Inc market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.15x | $48.44 Million | $42.00 Million | $3.99 Million | — |